Life Sciences

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 1 of 4

Saama Chief Strategy Officer Sagar Anisingaraju participated in a panel discussion titled “Future Visions: Are We Heading to Heaven, Hell or Purgatory?” at MAGI’s Clinical Research Conference – 2019 West. The following is Part 1 of 4 installments of the discussion, moderated by Jonathan Zung, Ph.D., member of Saama’s Clinical Board of Advisors and EVP, WCG.

Read More

Managing Site and Study Performance in Clinical Trials with AI

Clinical trials are extremely expensive and are often fraught with delays. With the increasing complexity of clinical trials, the cost and delays tend to increase and add to the potential risk-factors as well. The pharmaceutical industry is leveraging AI technology to streamline clinical study processes and make them more efficient. It has already made a…

Read More

Patient Safety Made More Effective with ML-Enabled Solutions

Patients’ safety is the top priority in any clinical trial. The data safety and monitoring services (DSMC) are there to ensure that the clinical studies are safe and run in accordance with regulations. The medical monitors observe the study in critical detail to ensure patient safety is assured. While medical monitors are here to keep…

Read More

Advancing Outcomes-Based AI to Interact with Trial Data

Only two months into 2019, Saama is excited to announce a capabilities expansion for its Deep Learning Intelligent Assistant (DaLIA). DaLIA, a context and domain-aware conversational user interface for Saama’s Life Science Analytics Cloud (LSAC), was launched in 2018 and shifted the human-computer interaction paradigm. DaLIA’s new, heightened functionality reinforces Saama’s position as an industry…

Read More

Mitigate Risks with AI Capability

One of the major challenges of managing clinical trials is collecting and applying relevant and important performance metrics. These Key Performance Indicators (KPIs) are used to monitor quality and efficiency of the processes. There are many operational parameters that need monitoring, a few of them being: First and last site activated First and last patient…

Read More

Saama’s New Patent and Why it Matters

Saama’s expertise as a leading data analytics innovator continues to be recognized, with the company having just been awarded a new patent, “Systems and Methods for Analyzing Consumer Sentiment with Social Perspective Insight.” This patent focuses on a system which is adaptive, making data harmonization and systems of engagement within systems of intelligence more fluid. Through smart metadata…

Read More

Insights-Driven Trial Planning – Better Decisions for Better Trial Outcomes

This is Part #2 of a blog series describing how disruptive innovation technologies such as Saama’s Life Science Analytics Cloud is enabling the Pharma industry to bend its clinical development cost curve sharply downwards while bringing cures to patients sooner.  This blog, co-authored by Nekzad Shroff  and Amit Gulwadi , explains the ROI benefits of improved trial planning decisions…

Read More

Clinical Trial Excellence for Tomorrow and Beyond Blog Series Concluding Post

In September, Saama initiated a novel blog series, Clinical Trial Excellence for Tomorrow and Beyond, which proudly showcased the experience and expertise of the six newest members of Saama’s Clinical Board of Advisors. These stellar professionals offered insightful commentary and informed predictions about the current and future role AI-enabled data analytics will play in the life science industry’s ongoing clinical development efforts.

Read More

Saama to the Rescue: Trial Manager

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Cost Considerations: Data Analytics for Biotech Clinical Trials

This week concludes Saama’s Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which has been authored by one of our six new Clinical Board of Advisor members. In this final post, Jay Kaminski  , Chief Operating Officer at Celularity and former Senior Vice President of Global Clinical Research & Development Operations at Celgene Corporation, explores the challenges…

Read More

Related Posts